This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Bull Of The Day: Tesla (TSLA)
by Brian Bolan
A monster short squeeze is right around the corner as the bears give up and are forced to buy the stock at much higher prices.
Is the Options Market Predicting a Spike in Herbalife Nutrition (HLF) Stock?
by Zacks Equity Research
Investors need to pay close attention to Herbalife Nutrition (HLF) stock based on the movements in the options market lately.
Top Ranked Momentum Stocks to Buy for May 22nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 22nd:
Bearish On Tesla? Not After Looking At These Charts
by Brian Bolan
Tesla bears will say anything to get you to sell your stock, but bulls can point to simple facts about demand to prove their point.
Will Soft Volumes Hurt Herbalife (HLF) This Earnings Season?
by Zacks Equity Research
Herbalife's (HLF) first-quarter 2018 performance is likely to gain from innovations and technological advancements. However, soft volumes are a concern.
Herbalife (HLF) Q4 Earnings Likely to Fall Y/Y: Here's Why
by Zacks Equity Research
Herbalife (HLF) has long been grappling with soft volumes, especially in its North American and Mexico operations. Unfortunately, this trend lingered in Q4.
Herbalife (HLF) Continues to Grapple With Lower Sales Volume
by Zacks Equity Research
Herbalife's (HLF) initial regional volume metrics for fourth-quarter 2017 is unimpressive. The company continues to battle weak market trends across North America and Mexico.
NVIDIA, Herbalife, Fossil Group, 1-800-Flowers.com and Pandora Media highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
NVIDIA, Herbalife, Fossil Group, 1-800-Flowers.com and Pandora Media highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Herbalife (HLF)
by Kevin Cook
As Ackman covers his short stock position and limps into puts, Wall Street banks are getting quieter too
Options Traders Expect Huge Moves in Herbalife (HLF) Stock
by Zacks Equity Research
Surging implied volatility makes Herbalife (HLF) stock lucrative to the option traders.
Is Soft Volume a Concern for Herbalife (HLF) in Q3 Earnings?
by Zacks Equity Research
Herbalife (HLF) is slated to post 3Q17 earnings. While the company remains focused on stringent cost management, soft volumes and unfavorable currency translations remain concerns.
Herbalife Buys 6.7 Million Shares Through Self-Tender Offer
by Zacks Equity Research
Herbalife (HLF) declares the results of its self-tender offer, incurring total cash outlay of $457.8 million. The number is lower than its initial offer to repurchase $600 million worth common stock.
Herbalife Up 11% Post Self-Tender Offer Preliminary Results
by Zacks Equity Research
The preliminary count exhibits unwillingness amongst investors to sell Herbalife's (HLF) stock under the self-tender offer. This has aided to drive the company's shares.
Herbalife (HLF) Soars: Stock Adds 11.2% in Session
by Zacks Equity Research
Herbalife (HLF) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
Why Did Shopify (SHOP) Stock Slump Today?
by Ryan McQueeney
Shares of Shopify (SHOP) fell more than 10% after notorious short-selling firm Citron Research argued that the e-commerce platform is fraudulently promoting "get-rich-quick schemes."
Will Herbalife's Upbeat Earnings View Help Lift the Stock?
by Zacks Equity Research
Herbalife (HLF) recently raised its earnings view for the upcoming third-quarter 2017 results. Nevertheless, shares of the company have remained dismal owing to declining sales volume.
Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?
by Zacks Equity Research
Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.
What FTC's Curtail on RAD Store Purchase Means for Walgreens?
by Zacks Equity Research
Walgreens' (WBA) purchase of lesser number of Rite Aid stores upsets investors. Let's draw an insight from this.
4 Growth Picks in Retail That Surged More Than 20% This Year
by Zacks Equity Research
These four retail stocks with solid bull-run and favorable Growth Score offer double treat.
Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens
by Zacks Equity Research
After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.
Walgreens to Revisit Rite Aid Deal for Antitrust Approval
by Zacks Equity Research
The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.
Options Traders Expect Huge Moves in Herbalife (HLF) Stock
by Zacks Equity Research
Investors in Herbalife (HLF) need to pay close attention to the stock based on moves in the options market lately.
Is Herbalife (HLF) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Herbalife Ltd. (HLF) stock is a good choice for value-oriented investors right now from multiple angles.
Herbalife (HLF) Catches Eye: Stock Jumps 9.8%
by Zacks Equity Research
Herbalife Ltd. (HLF) was a big mover last session, as the company saw its shares rise over 9% on the day.
Here's Why Herbalife (HLF) Stock Jumped Today
by Megan Sanks
Shares of Herbalife (HLF) popped 11% in morning trading on Monday after the company said that it held talks to go private last week, but discussions ended without a deal.